Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Marshall Wace LLP

Marshall Wace LLP reduced its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 59.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,476 shares of the medical instruments supplier's stock after selling 5,080 shares during the period. Marshall Wace LLP owned 0.06% of Mesa Laboratories worth $458,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of MLAB. Amundi boosted its position in Mesa Laboratories by 81.6% during the 4th quarter. Amundi now owns 661 shares of the medical instruments supplier's stock valued at $91,000 after purchasing an additional 297 shares during the period. Resona Asset Management Co. Ltd. bought a new position in shares of Mesa Laboratories during the fourth quarter valued at $92,000. KLP Kapitalforvaltning AS bought a new position in Mesa Laboratories in the fourth quarter valued at about $132,000. Berry Wealth Group LP lifted its holdings in Mesa Laboratories by 5.3% during the fourth quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier's stock worth $219,000 after acquiring an additional 83 shares in the last quarter. Finally, Pacer Advisors Inc. increased its holdings in Mesa Laboratories by 4.3% during the fourth quarter. Pacer Advisors Inc. now owns 1,755 shares of the medical instruments supplier's stock worth $231,000 after buying an additional 73 shares during the last quarter. Institutional investors and hedge funds own 90.60% of the company's stock.

Mesa Laboratories Stock Performance

Shares of NASDAQ MLAB traded down $0.81 during trading hours on Friday, reaching $124.73. 10,593 shares of the stock were exchanged, compared to its average volume of 39,114. The firm has a market capitalization of $677.78 million, a price-to-earnings ratio of -2.70 and a beta of 0.97. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71. The stock's fifty day simple moving average is $119.48 and its 200 day simple moving average is $126.43. Mesa Laboratories, Inc. has a 52 week low of $83.68 and a 52 week high of $155.12.

Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last posted its earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 EPS for the quarter, topping the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 104.92% and a positive return on equity of 30.23%. Sell-side analysts predict that Mesa Laboratories, Inc. will post 8 EPS for the current year.

Mesa Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 30th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.64 annualized dividend and a yield of 0.51%. Mesa Laboratories's payout ratio is -1.38%.

Insider Activity at Mesa Laboratories

In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total transaction of $2,602,110.00. Following the completion of the sale, the chief executive officer now directly owns 43,337 shares of the company's stock, valued at approximately $5,369,887.67. This represents a 32.64 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 4.40% of the stock is owned by corporate insiders.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.